pharma · Advanced Refractory Solid Tumors
Cstone Pharmaceuticals Ireland Limited
CStone Pharmaceuticals drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
CStone Pharmaceuticals drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
US regulatory status: approved. Molecular target: Discoidin domain-containing receptor 2.